KrishanRatilalJethwaMD

Physician

Dr. Jethwa is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Mayo Clinic College of Medicine and Science (Rochester)Residency, Radiation Oncology, 2015 - 2019
University of North Dakota School of Medicine and Health SciencesClass of 2014

PubMed

2 citations
Practice Patterns Related to Mitigation of Neurocognitive Decline in Patients Receiving Whole Brain Radiation Therapy.
Vikram Jairam, Henry S Park, James B Yu, Ranjit S Bindra, Joseph N Contessa
Advances in Radiation Oncology. 2022-03-21
125 citations
Prostate cancer-specific PET radiotracers: A review on the clinical utility in recurrent disease.
Jaden D. Evans, Krishan R. Jethwa, Piet Ost, Scott Williams, Eugene D. Kwon
Practical Radiation Oncology. 2018-01-01
19 citations
Effect of Targeted Therapies on Prognostic Factors, Patterns of Care, and Survival in Patients With Renal Cell Carcinoma and Brain Metastases
Paul W. Sperduto, Brian J. Deegan, Jing Li, Krishan R. Jethwa, Paul D. Brown
International Journal of Radiation Oncology, Biology, Physics. 2018-07-15

Smilow Cancer Hospital Care Center at Waterford Physician Makes ‘Top Docs’ List in ConnecticutJune 23rd, 2021
$Moderately Hypofractionated Photon and Proton Chemoradiotherapy as Definitive or Neoadjuvant Therapy in Non-Metastatic Pancreas Cancer with Assessment of Treatment Response Utilizing Molecular Biomarkers$
Moderately Hypofractionated Photon and Proton Chemoradiotherapy as Definitive or Neoadjuvant Therapy in Non-Metastatic Pancreas Cancer with Assessment of Treatment Response Utilizing Molecular BiomarkersApril 4th, 2019